Simon P. Baker

Partner and Head of Global Biopharma Research at Redburn at Redburn Atlantic

Simon P. Baker is a Partner and Head of Global Biopharma Research at Redburn Atlantic, specializing in biopharmaceutical equity research with deep coverage of leading companies such as AstraZeneca, Novo Nordisk, Roche Holding AG, Abbott Laboratories, Hologic, Qiagen, BioNTech, and Moderna. His track record includes 17 ratings with a 33% success rate and an average return of -6.4%, ranking him #7,833 out of nearly 10,000 Wall Street analysts, with notable profitable calls like a +11.8% return on BioNTech. Baker began his finance career at Lehman Brothers in 2000, followed by roles at Credit Suisse, Occitan Capital Partners, Oriel Securities, and Exane, before joining Redburn in March 2019. He holds a Ph.D. in Organic Chemistry from Imperial College London and is a CFA charterholder, reflecting his rigorous professional credentials.